Clinical Trials in Jinan, Shangdong
21 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Generalized Myasthenia Gravis
Vor Biopharma180 enrolled105 locationsNCT06456580
Recruiting
Phase 3
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD190 enrolled63 locationsNCT05652894
Recruiting
Phase 3
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
Non-small Cell Lung Cancer
Nuvation Bio Inc.194 enrolled29 locationsNCT06564324
Recruiting
Not Applicable
Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
Stroke
Qilu Hospital of Shandong University86 enrolled1 locationNCT06704074
Recruiting
Not Applicable
Effect of Predictive Model on Double-Balloon Enteroscopy
Double-balloon Enteroscopy
Shandong University338 enrolled5 locationsNCT07288346
Recruiting
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China1,500 enrolled9 locationsNCT06900062
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
Non-small Cell Lung CancerSolid Tumor Cancer
Shanghai Henlius Biotech105 enrolled3 locationsNCT06848699
Recruiting
Phase 1
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Chronic Kidney DiseasesRenal Transplantation
Qianfoshan Hospital30 enrolled1 locationNCT07045467
Recruiting
Phase 1
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Sichuan Baili Pharmaceutical Co., Ltd.130 enrolled8 locationsNCT05924750
Recruiting
Phase 1Phase 2
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Safety IssuesTolerabilityPharmacokinetics
Nanjing Immunophage Biotech Co., Ltd196 enrolled7 locationsNCT05142592
Recruiting
Phase 2
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC
Carcinoma, Non-Small Cell Lung
Shandong Public Health Clinical Center30 enrolled1 locationNCT06709859
Recruiting
Phase 4
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
Antiphospholipid (aPL)-PositiveThrombocytopaenia
Peking University First Hospital84 enrolled10 locationsNCT06722586
Recruiting
Phase 1
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.153 enrolled20 locationsNCT05473624
Recruiting
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled58 locationsNCT06760273
Recruiting
Phase 4
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled63 locationsNCT06093191
Recruiting
Phase 2
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
Changzhou Qianhong Bio-pharma Co., Ltd.53 enrolled10 locationsNCT06532058
Recruiting
Phase 2
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd.90 enrolled11 locationsNCT06155383
Recruiting
Phase 1
A Study to Investigate FP002 in Subjects With Advanced Malignancies
Advanced Solid Tumor
Guangdong Fapon Biopharma Inc.27 enrolled3 locationsNCT05982080